The report covers forecast and analysis for the pruritus therapeutics market on a global and regional level. The study provides historic data of 2014 and 2015 along with a forecast from 2016 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the pruritus therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Pruritus therapeutics market on a global level. This report offers comprehensive coverage on global pruritus therapeutics market along with, market trends, drivers, and restraints of Pruritus therapeutics market. This report includes a detailed competitive scenario and technology portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the pruritus therapeutics market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from... Research Beam Model: Research Beam Product ID: 1592120 4199 USD New
Pruritus Therapeutics Market (Antihistamines, Topical Corticosteroids, Opioid Receptor Antagonists, Topical Immunomodulators, Antidepressants, Immunosuppressants, Topical Local Anesthetics, Cannabinoid Receptors and Others): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Pruritus Therapeutics Market (Antihistamines, Topical Corticosteroids, Opioid Receptor Antagonists, Topical Immunomodulators, Antidepressants, Immunosuppressants, Topical Local Anesthetics, Cannabinoid Receptors and Others): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

 
 
 


The report covers forecast and analysis for the pruritus therapeutics market on a global and regional level. The study provides historic data of 2014 and 2015 along with a forecast from 2016 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the pruritus therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Pruritus therapeutics market on a global level.

This report offers comprehensive coverage on global pruritus therapeutics market along with, market trends, drivers, and restraints of Pruritus therapeutics market. This report includes a detailed competitive scenario and technology portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the pruritus therapeutics market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report.

The study provides a decisive view on the pruritus therapeutics market by segmenting the market based on therapeutic type and regions. All these segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2022. The therapeutic type based market covered under this study includes antihistamines, topical corticosteroids, opioid receptor antagonists, topical immunomodulators, antidepressants, immunosuppressants, topical local anesthetics, cannabinoid receptors and others. This report also includes the current and forecast demand for the region of North America, Europe, Asia-Pacific, Latin America and the Middle East Africa.

Key operating players in pruritus therapeutics market are like Brunswick Corporation, Johnson Health Tech Co. Ltd., Nautilus Strength, Icon Health Fitness, Amer Sports, Technogym, Precor incorporated and Cybex International Inc.

This report segments the pruritus therapeutics market as follows:

Global Pruritus Therapeutics Market: Therapeutic Type Analysis
Antihistamines
Topical Corticosteroids
Opioid Receptor Antagonists
Topical Immunomodulators
Antidepressants
Immunosuppressants
Topical Local Anesthetics
Cannabinoid Receptors
Other

Global Pruritus Therapeutics Market: Regional Analysis
North America
U.S.
Europe
U.K.
Germany
France
Asia
India
China
Japan
Latin America
Brazil
Middle East and Africa
Chapter 1. Introduction 1.1. Report Description And Scope 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology Chapter 2. Executive Summary 2.1. Global Pruritus Therapeutics Market, 2014 - 2022 (USD Billion) 2.2. Global Pruritus Therapeutics Market: Snapshot Chapter 3. Pruritus Therapeutics Market Market Dynamics 3.1. Introduction 3.2. Value Chain Analysis 3.3. Market Drivers 3.3.1. Global Pruritus Therapeutics Market drivers: Impact Analysis 3.3.2. increasing prevalence of atopic dermatitis 3.3.3. Development of new drug and a strong pipeline 3.4. Global Pruritus Therapeutics Market Restraints: Impact Analysis 3.4.1. Lack of awareness about pruritus 3.5. Opportunities 3.5.1. Untapped market and increasing number of patent expiry of pruritus drugs 3.6. Porters Five Forces Analysis 3.6.1. Bargaining Power Of Suppliers 3.6.2. Bargaining Power Of Buyers 3.6.3. Threat From New Entrants 3.6.4. Threat From New Substitutes 3.6.5. Degree Of Competition 3.7. Market Attractiveness Analysis 3.7.1. Market Attractiveness Analysis, by therapeutic segment 3.7.2. Market Attractiveness Analysis, by Regional Segment Chapter 4. Global Pruritus Therapeutics Market Competitive Landscape 4.1. Company Market Share, 2014 (Subject To Data Availability) 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Source Launch 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures 4.2.4. Research And Development, Therapeutic And Regional Expansion 4.3. Technology Portfolio 4.4. Patent Analysis (2011-2015) 4.4.1. Patent Trend 4.4.2. Patent Share By Company 4.4.3. By Region Chapter 5. Global Pruritus Therapeutics Market Therapeutic Analysis 5.1. Global Pruritus Therapeutics Market: Therapeutic Segment Overview 5.1.1. Global Pruritus Therapeutics Market Revenue Share, By Therapeutic Segment, 2014 And 2022 5.2. Antihistamines 5.2.1. Global Pruritus Therapeutics Market For Antihistamines, 2014 - 2022 (USD Billion) 5.3. Topical Corticosteroids 5.3.1. Global Pruritus Therapeutics Market For Topical Corticosteroids, 2014 - 2022 (USD Billion 5.4. Opioid Receptor Antagonists 5.4.1. Global Pruritus Therapeutics Market For Opioid Receptor Antagonists, 2014 - 2022 (USD Billion) 5.5. Topical Immunomodulators 5.5.1. Global Pruritus Therapeutics Market For Topical Immunomodulators, 2014 - 2022 (USD Billion) 5.6. Antidepressants 5.6.1. Global Pruritus Therapeutics Market For Antidepressants , 2014 - 2022 (USD Billion) 5.7. Immunosuppressants 5.7.1. Global Pruritus Therapeutics Market For Immunosuppressants, 2014 - 2022 (USD Billion) 5.8. Topical Local Anesthetics 5.8.1. Global Pruritus Therapeutics Market For Topical Local Anesthetics, 2014 - 2022 (USD Billion) 5.9. Cannabinoid Receptors 5.9.1. Global Pruritus Therapeutics Market For Cannabinoid Receptors, 2014 - 2022 (USD Billion) 5.10. Others 5.10.1. Global Pruritus Therapeutics Market For others, 2014 - 2022 (USD Billion) Chapter 6. Global Pruritus Therapeutics Market Regional Segment Analysis 6.1. Global Pruritus Therapeutics Market: Regional Overview 6.1.1. Global Pruritus Therapeutics Market Revenue Share, By Region, 2014 And 2020 6.2. North America 6.2.1. North America Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion) 6.2.2. U.S. 6.2.2.1. U.S. Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million) 6.3. Europe 6.3.1. Europe Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion) 6.3.2. U.K. 6.3.2.1. U.K. Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million) 6.3.3. Germany 6.3.3.1. Germany Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million) 6.3.4. France 6.3.4.1. France Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million) 6.4. Asia Pacific 6.4.1. Asia Pacific Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion) 6.4.2. India 6.4.2.1. India Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million) 6.4.3. China 6.4.3.1. China Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million) 6.4.4. Japan 6.4.4.1. Japan Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million) 6.5. Latin America 6.5.1. Latin America Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion) 6.5.2. Brazil 6.5.2.1. Brazil Pruritus Therapeutics Market Revenue, by therapeutic type classification, 2014 - 2022 , (USD Million) 6.6. Middle East and Africa 6.6.1. Middle East and Africa Pruritus Therapeutics Market Revenue, by therapeutic 2014 - 2022 , (USD Billion) Chapter 7. Company Profile 7.1. Allergan Inc. 7.1.1. Overview 7.1.2. Financials 7.1.3. Technology Portfolio 7.1.4. Business Strategy 7.1.5. Recent Developments 7.2. Amgen Inc. 7.2.1. Overview 7.2.2. Financials 7.2.3. Technology Portfolio 7.2.4. Business Strategy 7.2.5. Recent Developments 7.3. Astellas Pharma Inc. 7.3.1. Overview 7.3.2. Financials 7.3.3. Technology Portfolio 7.3.4. Business Strategy 7.3.5. Recent Developments 7.4. CARA Therapeutics 7.4.1. Overview 7.4.2. Financials 7.4.3. Technology Portfolio 7.4.4. Business Strategy 7.4.5. Recent Developments 7.5. Novartis AG 7.5.1. Financials 7.5.2. Technology Portfolio 7.5.3. Business Strategy 7.5.4. Recent Developments 7.6. Teva Pharmaceutical Industries Ltd. 7.6.1. Financials 7.6.2. Technology Portfolio 7.6.3. Business Strategy 7.6.4. Recent Developments 7.7. Ajanta Pharma ltd. 7.7.1. Overview 7.7.2. Financials 7.7.3. Technology Portfolio 7.7.4. Business Strategy 7.7.5. Recent Developments 7.8. Abbot lab 7.8.1. Overview 7.8.2. Financials 7.8.3. Technology Portfolio 7.8.4. Business Strategy 7.8.5. Recent Developments 7.9. GlaxoSmithKline plc. 7.9.1. Overview 7.9.2. Financials 7.9.3. Technology Portfolio 7.9.4. Business Strategy 7.9.5. Recent Developments 7.10. Galderma 7.10.1. Overview 7.10.2. Financials 7.10.3. Technology Portfolio 7.10.4. Business Strategy 7.10.5. Recent Developments